Dr. Scott E. Delacroix
Claim this profileLSU Healthcare Network / Metairie Multi-Specialty Clinic
About Scott E. Delacroix
Education:
- Received MD (Doctor of Medicine) from Louisiana State University School of Medicine, New Orleans, in 1987.
Experience:
- Board Certified in Internal Medicine by the American Board of Internal Medicine.
- Currently practicing at LSU Healthcare Network / Metairie Multi-Specialty Clinic.
Area of expertise
Prostate Cancer
Scott E. Delacroix has run 12 trials for Prostate Cancer. Some of their research focus areas include:
Bladder Cancer
Scott E. Delacroix has run 9 trials for Bladder Cancer. Some of their research focus areas include:
Affiliated Hospitals
LSU Healthcare Network / Metairie Multi-Specialty Clinic
East Jefferson General Hospital
Clinical Trials Scott E. Delacroix is currently running
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting
2 awards
Phase 3
30 criteria
Relugolix + Radiation
for Advanced-Stage Prostate Cancer
This phase II trial compares the usual treatment of radiation therapy alone to using the study drug, relugolix, plus the usual radiation therapy in patients with castration-sensitive prostate cancer that has spread to limited other parts of the body (oligometastatic). Relugolix is in a class of medications called gonadotropin-releasing hormone (GnRH) receptor antagonists. It works by decreasing the amount of testosterone (a male hormone) produced by the body. It may stop the growth of cancer cells that need testosterone to grow. Radiation therapy uses high-energy x rays or protons to kill tumor cells. The addition of relugolix to the radiation may reduce the chance of oligometastatic prostate cancer spreading further.
Recruiting
0 awards
Phase 2
More about Scott E. Delacroix
Clinical Trial Related
5 years of experience running clinical trials · Led 28 trials as a Principal Investigator · 11 Active Clinical Trials
Treatments Scott E. Delacroix has experience with
- Gemcitabine Hydrochloride
- Radiation Therapy
- Bicalutamide
- Flutamide
- Atezolizumab
- Docetaxel
Breakdown of trials Scott E. Delacroix has run
Prostate Cancer
Bladder Cancer
Prostate Adenocarcinoma
Kidney Cancer
Urothelial Carcinoma
- Immune Checkpoint Therapy Duration for Bladder Cancer
- Durvalumab + Chemotherapy for Urothelial Carcinoma
- Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott E. Delacroix specialize in?
Scott E. Delacroix focuses on Prostate Cancer and Bladder Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are synaptophysin positive.
Is Scott E. Delacroix currently recruiting for clinical trials?
Yes, Scott E. Delacroix is currently recruiting for 11 clinical trials in Metairie Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Scott E. Delacroix has studied deeply?
Yes, Scott E. Delacroix has studied treatments such as Gemcitabine Hydrochloride, Radiation Therapy, Bicalutamide.
What is the best way to schedule an appointment with Scott E. Delacroix?
Apply for one of the trials that Scott E. Delacroix is conducting.
What is the office address of Scott E. Delacroix?
The office of Scott E. Delacroix is located at: LSU Healthcare Network / Metairie Multi-Specialty Clinic, Metairie, Louisiana 70006 United States. This is the address for their practice at the LSU Healthcare Network / Metairie Multi-Specialty Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.